{"entity":{"id":"idea-pu-contrast-switch-agent-after-reaction","kind":"idea","name":"Switching to a different contrast agent, chosen by allergy testing, instead of steroid premedication after a reaction","aka":[],"tldr":"People who reacted to a contrast dye are often given steroid tablets before their next scan with the same dye. In a large study, people given a different dye had a repeat reaction in 3 per cent of scans, against 19 per cent with the same dye and steroids. European radiologists now recommend changing the dye, ideally after allergy testing, and say premedication has a narrow place.","summary":"The evidence. McDonald and colleagues reviewed 1,973 people with a previous allergic-like reaction who had 4,360 later contrast CT scans at one United States centre between 2009 and 2017. Repeat reactions occurred in 80 of 423 examinations (19 per cent) with the same contrast agent and steroid premedication, and in 10 of 322 (3 per cent) with a different agent and no steroids (odds ratio 0.14, 95 per cent confidence interval 0.06 to 0.33). At the first repeat scan, people given the same agent reacted at the same rate with or without steroids (26 per cent against 25 per cent). It is a retrospective single-centre cohort, not a trial.\n\nThe guideline. The ESUR Contrast Media Safety Committee (European Radiology 2025) recommends referring at least everyone with a moderate or severe reaction to a drug allergy specialist and choosing an alternative agent from the allergy evaluation, which it calls safer and more effective than premedication. It cites an American allergology guideline finding evidence lacking for corticosteroid premedication, and notes that steroids can raise blood glucose. The ACR Manual on Contrast Media, the main source of North American premedication regimens, could not be read for this record, so the North American position is named but not quoted.\n\nThe open questions. There is no randomised comparison of switching against premedication, allergy services able to test contrast agents are scarce in many places, and how often departments switch rather than premedicate has not been measured.","asOf":"2026-11-11","links":[{"label":"McDonald et al., Prevention of allergic-like reactions at repeat CT: steroid pretreatment versus contrast material substitution (Radiology 2021)","url":"https://doi.org/10.1148/radiol.2021210490"},{"label":"van der Molen et al., Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee (European Radiology 2025)","url":"https://doi.org/10.1007/s00330-025-11676-0"},{"label":"ESUR Contrast Media Safety Committee Guidelines 2026","url":"https://www.esur.org/wp-content/uploads/2026/10/Guidelines-2026.pdf"}],"tags":["protocol-upgrade","upgrade:promising","evidence:moderate"],"related":[],"cancers":[],"sections":["imaging"],"technologies":["iodinated-contrast-media","ct"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":["b-toxicity-qol","b-knowledge-diffusion"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hypothesis":"After a contrast reaction, recording the culprit agent and switching to a structurally different agent (chosen by skin testing where available) halves repeat reactions compared with the same agent under steroid cover, without delaying cancer imaging.","rationale":"The best data available show premedication with the same agent barely changes the repeat rate, while switching cuts it several-fold; switching costs nothing once the culprit is recorded, and avoids steroid side effects in people who may be diabetic or on chemotherapy.","test":"A pragmatic randomised or cluster-randomised comparison, in people with a prior mild or moderate immediate reaction needing repeat contrast CT, of switching agent without premedication against the same agent with standard steroid premedication, with repeat reaction as the primary endpoint.","maturity":"early-clinical","actor":"clinic","cost":"small","horizonYears":3},"route":"/ideas/idea-pu-contrast-switch-agent-after-reaction/","neighbours":{"section":[{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"}],"technology":[{"id":"ct","kind":"technology","name":"CT (computed tomography)","route":"/technologies/ct/"},{"id":"iodinated-contrast-media","kind":"technology","name":"Iodinated and barium contrast for CT and X-ray","route":"/technologies/iodinated-contrast-media/"}],"bottleneck":[{"id":"b-knowledge-diffusion","kind":"bottleneck","name":"Knowledge reaches practice too slowly","route":"/bottlenecks/b-knowledge-diffusion/"},{"id":"b-toxicity-qol","kind":"bottleneck","name":"Toxicity and quality of life are undervalued","route":"/bottlenecks/b-toxicity-qol/"}],"protocol":[{"id":"contrast-reaction-history-and-premedication","kind":"protocol","name":"Contrast scans after a previous contrast reaction: allergy referral, switching agent and premedication","route":"/protocols/contrast-reaction-history-and-premedication/"}]}}